Raptor Pharmaceutical Corp (NASDAQ:RPTP)
During the Trading Day
| 6.40 |  -0.29 / -4.33% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 6.40 |  0.00 / 0.00% |
Volume: 4,000.00 |
Latest RPTP News | Press Releases
No recent news for Raptor Pharmaceutical Corp.
Today’s Trading
| Previous close | 6.69 |
| Today’s open | 6.67 |
| Day’s range | 6.26 - 6.95 |
| Volume | 446,389 |
| Average volume (3 months) | 697,178 |
| Market cap | $370.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +30.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TSRXTrius Therapeutics I... | -0.17 | -2.19% |
| SCMPSucampo Pharmaceutic... | -0.33 | -3.69% |
| ENTAEnanta Pharmaceutica... | -0.34 | -1.67% |
| INSMInsmed Inc | +1.11 | +9.80% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$38.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Christopher M. Starr, PhD |
Chief Operating Officer & Executive VP-Strategy Julie Anne Smith |
Corporate headquarters Novato, California |
Forecasts
